Abbott Laboratories ROE 2006-2018 | ABT
Current and historical return on equity (ROE) values for Abbott Laboratories (ABT) over the last 10 years.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.003B | $27.390B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $118.964B | 18.41 |
| Stryker (SYK) | United States | $64.929B | 25.97 |
| Boston Scientific (BSX) | United States | $46.555B | 25.95 |
| Baxter (BAX) | United States | $40.001B | 28.62 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.844B | 14.39 |
| ResMed (RMD) | United States | $15.490B | 32.39 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.465B | 0.00 |
| Perrigo (PRGO) | Ireland | $10.581B | 14.84 |
| Bio-Rad Laboratories (BIO) | United States | $9.046B | 72.96 |
| Hill-Rom Holdings (HRC) | United States | $6.207B | 22.30 |
| ICU Medical (ICUI) | United States | $6.175B | 57.46 |
| Canopy Growth (CGC) | Canada | $5.749B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $5.297B | 0.00 |
| Insulet (PODD) | United States | $5.208B | 0.00 |
| Haemonetics (HAE) | United States | $5.062B | 52.13 |
| Hutchison China MediTech (HCM) | China | $4.438B | 0.00 |
| Neogen (NEOG) | United States | $4.224B | 67.54 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.134B | 0.00 |
| National Vision Holdings (EYE) | United States | $3.060B | 0.00 |
| NuVasive (NUVA) | United States | $2.724B | 27.53 |
| Quidel (QDEL) | United States | $2.634B | 115.26 |
| Phibro Animal Health (PAHC) | United States | $1.934B | 28.71 |
| Abaxis,Inc (ABAX) | United States | $1.905B | 64.07 |
| NxStage Medical (NXTM) | United States | $1.857B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.424B | 21.94 |
| Eagle Pharmaceuticals (EGRX) | United States | $1.224B | 34.22 |
| Cardiovascular Systems (CSII) | United States | $1.172B | 0.00 |
| Orthofix (OFIX) | $1.095B | 33.36 | |
| Owens & Minor (OMI) | United States | $1.066B | 10.71 |
| OraSure Technologies (OSUR) | United States | $1.019B | 61.81 |
| AtriCure (ATRC) | United States | $1.017B | 0.00 |
| Omeros (OMER) | United States | $0.968B | 0.00 |
| Cerus (CERS) | United States | $0.960B | 0.00 |
| MacroGenics (MGNX) | United States | $0.920B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.893B | 0.00 |
| Surmodics (SRDX) | United States | $0.786B | 134.66 |
| LeMaitre Vascular (LMAT) | United States | $0.710B | 41.78 |
| Meridian Bioscience (VIVO) | United States | $0.661B | 23.28 |
| PetIQ (PETQ) | United States | $0.634B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.602B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.528B | 13.80 |
| Evolus (EOLS) | United States | $0.504B | 0.00 |
| Surface Oncology (SURF) | United States | $0.407B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.364B | 24.09 |
| Cytosorbents (CTSO) | United States | $0.356B | 0.00 |
| Quanterix (QTRX) | United States | $0.324B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.316B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.285B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.225B | 0.00 |
| Chimerix (CMRX) | United States | $0.220B | 0.00 |
| Fonar (FONR) | United States | $0.171B | 10.36 |
| Bovie Medical (BVX) | United States | $0.168B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.158B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.131B | 0.00 |
| Female Health (VERU) | United States | $0.113B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.105B | 31.25 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.098B | 0.00 |
| United-Guardian (UG) | United States | $0.089B | 20.91 |
| Neurotrope (NTRP) | United States | $0.085B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.075B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.056B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.049B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.037B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.035B | 0.00 |
| Myomo (MYO) | United States | $0.030B | 0.00 |
| Senestech (SNES) | United States | $0.025B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.011B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.003B | 0.00 |
